| Category | FY | Funding IC | Project Number | Sub Project # | Project Title | PI Name | Org Name | State / Country | Amount |
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NHLBI
|
5R01HL111516-06
|
|
Vascular Factors Underlying Abnormal Cognitive Aging
|
JEFFERSON, ANGELA
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
TN
|
$395,000
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NHLBI
|
5R01HL122658-03
|
|
Determinants of Midlife & Longitudinal Change in Cognitive Function: CARDIA Study
|
SIDNEY, STEPHEN
|
KAISER FOUNDATION RESEARCH INSTITUTE
|
CA
|
$740,757
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIEHS
|
5R01ES024936-03
|
|
Neurotoxicity of Airborne Particles: Role of Chronic Cerebral Hypoperfusion
|
MACK, WILLIAM
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
CA
|
$472,053
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
5K24AG046373-05
|
|
Risk factors and prevention targets for abnormal cognitive aging
|
JEFFERSON, ANGELA
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
TN
|
$164,429
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
5R21AG050049-02
|
|
Animal model of impaired autoregulation for study of age related vascular cognitive impairment
|
FAN, FAN
|
UNIVERSITY OF MISSISSIPPI MED CTR
|
MS
|
$228,750
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NICHD
|
5R01HD064993-08
|
|
Aging and Dementia in Down Syndrome: Connectivity, Inflammation, and Cerebrovascular Contributions
|
HEAD, ELIZABETH
|
UNIVERSITY OF KENTUCKY
|
KY
|
$496,429
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
5R01NS096730-02
|
|
CEREBRAL AMYLOID ANGIOPATHY AND MECHANISMS OF BRAIN AMYLOID ACCUMULATION
|
GREENBERG, STEVEN
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$96,654
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NINDS
|
5R01NS096730-02
|
|
CEREBRAL AMYLOID ANGIOPATHY AND MECHANISMS OF BRAIN AMYLOID ACCUMULATION
|
GREENBERG, STEVEN
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$1,321,009
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
1RF1AG054442-01
|
|
Brain atrophy, cognitive impairment and Alzheimer's in a low CVD-risk population
|
KAPLAN, HILLARD
|
UNIVERSITY OF NEW MEXICO
|
NM
|
$192,588
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
1RF1AG054548-01
|
|
MRI Measures of Cerebrovascular Injury and AD Atrophy in a Study of Latinos
|
DECARLI, CHARLES
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
CA
|
$14,695,967
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
1K01AG054700-01
|
|
Application of latent and integrative approaches to understand the spectrum of cognitive aging
|
ZAMMIT, ANDREA
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
NY
|
$130,545
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
1R21AG054802-01
|
|
PET imaging of soluble epoxide hydrolase (sEH) in human subjects
|
HORTI, ANDREW
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$285,822
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
5R01AG026484-13
|
|
Vascular Dysfunction in Cerebral Amyloid Angiopathy
|
GREENBERG, STEVEN
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$710,360
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
1R21AG054937-01
|
|
Role of diet-induced miR-34a in Alzheimer disease and dementia
|
FUKUCHI, KEN-ICHIRO
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
IL
|
$199,875
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NINDS
|
5R01NS017950-34
|
|
Precursors of Stroke Incidence and Prognosis
|
SESHADRI, SUDHA
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
MA
|
$828,217
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
1R21AG055034-01
|
|
Vascular Reserve and Protective Mechanisms in Aging and Alzheimer’s Dementia Risk
|
NATION, DANIEL
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
CA
|
$206,250
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NINDS
|
5K23NS086873-04
|
|
Genetic Analyses of Lipids in Cerebral Hemorrhage and Small Vessel Disease
|
ANDERSON, CHRISTOPHER
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$194,292
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
5U01AG029824-07
|
|
ASPirin in Reducing Events in the Elderly
|
MURRAY, ANNE
|
MINNEAPOLIS MEDICAL RESEARCH FDN, INC.
|
MN
|
$4,941,881
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
5K23AG045201-04
|
|
Vascular mechanisms for the effects of ovarian suppression on cognitive function
|
HILDRETH, KERRY
|
UNIVERSITY OF COLORADO DENVER
|
CO
|
$158,490
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
1RF1AG050782-01A1
|
|
Early Vascular Contributions to Dementia Risk in African-Americans
|
WHITMER, RACHEL
|
KAISER FOUNDATION RESEARCH INSTITUTE
|
CA
|
$3,818,380
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
1R01NS096173-01A1
|
|
Genetic and Mechanistic Study of Cerebral Small Vessel Disease
|
GOULD, DOUGLAS
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
CA
|
$771,932
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NINDS
|
5R01NS034467-19
|
|
Alzheimer's Abeta, apolipoproteins and blood-brain barrier
|
ZLOKOVIC, BERISLAV
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
CA
|
$599,100
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
5P50AG005142-33
|
5302
|
Neurovascular Factors in AD
|
ZLOKOVIC, BERISLAV
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
CA
|
$176,162
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
5K01AG044490-04
|
|
Peripheral & Brain Cholesterol Metabolism in Neurodegenerative Mouse Models
|
FITZ, NICHOLAS
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$92,587
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
5R01AG034374-08
|
|
Characterizing the Behavior Profile of Healthy Cognitive Aging
|
BOYLE, PATRICIA
|
RUSH UNIVERSITY MEDICAL CENTER
|
IL
|
$604,525
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
5P50AG005134-34
|
5900
|
Core B - Clinical Core
|
GOMEZ-ISLA, TERESA
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$832,933
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
5R01NS092696-02
|
|
Understanding the Origins of Amyloid Deposition in Cerebral Amyloid Angiopathy
|
VAN NOSTRAND, WILLIAM
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
NY
|
$49,375
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NINDS
|
5R01NS092696-02
|
|
Understanding the Origins of Amyloid Deposition in Cerebral Amyloid Angiopathy
|
VAN NOSTRAND, WILLIAM
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
NY
|
$345,625
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NHLBI
|
5R01HL131515-02
|
|
Endothelial function of amyloid precursor protein
|
KATUSIC, ZVONIMIR
|
MAYO CLINIC ROCHESTER
|
MN
|
$527,192
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NINDS
|
5R01NS085002-05
|
|
Cerebral Small Vessels in Motor and Cognitive Decline
|
SOROND, FARZANEH
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
IL
|
$447,036
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
5P50AG016574-19
|
5895
|
Project 1
|
VEMURI, PRASHANTHI
|
MAYO CLINIC ROCHESTER
|
MN
|
$181,526
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
5P50AG016574-19
|
5897
|
Project 3
|
BU, GUOJUN
|
MAYO CLINIC ROCHESTER
|
MN
|
$242,519
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NINDS
|
5K23NS083711-04
|
|
Molecular Neuroimaging of Disease Mechanisms in Cerebral Amyloid Angiopathy
|
GUROL, MAHMUT
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$201,960
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
5R01AG045154-04
|
|
Processing Speed Training to Preserve Driving and Functional Competencies in MCI
|
WADLEY BRADLEY, VIRGINIA
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$403,268
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
2R01AG019771-11A1
|
|
Memory Circuitry in MCI and Early Alzheimer’s Disease Prodrome: Molecular Drivers
|
SAYKIN, ANDREW
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
IN
|
$687,972
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
5K01AG049164-03
|
|
Genetic Resilience to the Clinical Manifestation of Dementia
|
HOHMAN, TIMOTHY
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
TN
|
$119,103
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
5P30AG008051-28
|
5041
|
Core D. Neuropathology Core (with IBR Subcontract)
|
WISNIEWSKI, THOMAS
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
NY
|
$192,336
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
5R01AG047827-04
|
|
The impact of non-amyloid processes on cognitive aging
|
DECARLI, CHARLES
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
CA
|
$558,089
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
5R21AG052321-02
|
|
Targeting Neurovascular Dysfunction in AD
|
BHAT, NARAYAN
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
SC
|
$186,875
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
5R44AG053121-02
|
|
Innovating Tablet-Based Cognitive Assessment for CNS Disorders of Aging
|
KEEFE, RICHARD
|
NEUROCOG TRIALS, INC.
|
NC
|
$660,103
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
5R01AG047879-04
|
|
Microvascular mechanisms of neuroinflammation: role of Nrf2
|
CSISZAR, ANNA
|
UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR
|
OK
|
$303,400
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
5P01AG025204-12
|
7674
|
Vascular Moderators of the Impact of Alzheimer's Pathology in the Oldest-Old
|
LOPEZ, OSCAR
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$361,207
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
5R21AG051932-02
|
|
Angiogenesis and Alzheimer’s Disease
|
CALLAHAN, CHRISTOPHER
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
IN
|
$193,757
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
3P30AG008017-28S1
|
7820
|
Neuroimaging Core
|
SILBERT, LISA
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
OR
|
$166,047
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
5R01AG021055-15
|
|
Clinical, Imaging, and Pathological Studies in the Oldest Old: The 90+ Study
|
KAWAS, CLAUDIA
|
UNIVERSITY OF CALIFORNIA-IRVINE
|
CA
|
$1,926,826
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
5R01AG045058-04
|
|
Genes, Exercise, Neurocognitive and Neurodegeneration: Community-Based Approach
|
OBISESAN, THOMAS
|
HOWARD UNIVERSITY
|
DC
|
$552,444
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NHLBI
|
5R01HL134320-02
|
|
Profiling Cardiovascular Events and Biomarkers in the Very Old to Improve Personalized Approaches for the Prevention of Cardiac and Vascular Disease
|
BALLANTYNE, CHRISTIE
|
BAYLOR COLLEGE OF MEDICINE
|
TX
|
$794,225
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
2P01AG041710-04
|
8278
|
Alzheimer's Disease and Related Dementias and Cognitive Impairment
|
BERKMAN, LISA
|
HARVARD SCHOOL OF PUBLIC HEALTH
|
MA
|
$189,682
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
5P50AG005138-33
|
5086
|
Project 3: Effects of Type 2 Diabetes (T2D) and Alzheimer disease (AD) on angiogenesis and angiogenic complexes
|
YOON, YONEJUNG
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
NY
|
$200,668
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
5R01AG045541-04
|
|
Role of lipid droplets in neurovascular inflammation
|
RUTLEDGE, JOHN
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
CA
|
$390,220
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
5R01AG047975-04
|
|
Vascular Pathology in Early and Asymptomatic Cerebral Amyloid Angiopathy
|
VISWANATHAN, ANAND
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$708,659
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
5R01AG048935-03
|
|
Modeling aerobic exercise regimens: prevention and amelioration of amyloid pathologies and cognitive impairment
|
VAN NOSTRAND, WILLIAM
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
NY
|
$323,900
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
1R01AG055559-01
|
|
Role of Tau Conformations in Vascular Contribution to Cognitive Impairment and Dementia
|
LU, KUN PING
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
MA
|
$704,410
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NHLBI
|
5U01HL131019-02
|
|
Underlying Mechanisms of Vascular Disease
|
IRUELA-ARISPE, M
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$544,907
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NINDS
|
5U01NS036695-16
|
|
Genetic and Environmental Risk Factors for Hemorrhagic Stroke
|
WOO, DANIEL
|
UNIVERSITY OF CINCINNATI
|
OH
|
$1,380,310
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
5R01AG046205-05
|
|
ApoE isoform-specific therapy for Alzheimer disease
|
BU, GUOJUN
|
MAYO CLINIC JACKSONVILLE
|
FL
|
$320,825
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NHLBI
|
1R01HL136636-01
|
|
Capillary control of cerebral blood flow, and its disruption in small vessel disease
|
DABERTRAND, FABRICE
|
UNIVERSITY OF VERMONT & ST AGRIC COLLEGE
|
VT
|
$400,844
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NINR
|
5R01NR010827-10
|
|
Cerebrovascular Contributions to Brain Aging and Dementia
|
SALAT, DAVID
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$559,344
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
1R21AG055749-01
|
|
Automated Assessment of Cognitive Tests for Detecting Mild Cognitive Impairment
|
ASGARI, MEYSAM
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
OR
|
$184,739
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
1R21NS101506-01
|
|
Olive-derived oleocanthal as a novel natural product molecule to restore cerebrovascular function and integrity in a CAA mouse model
|
KHALIL KADDOUMI, AMAL
|
AUBURN UNIVERSITY AT AUBURN
|
AL
|
$219,493
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NINDS
|
5R01NS086882-04
|
|
Neuroimaging and Neuropsychological Biomarkers of Vascular Risk Factors
|
LERITZ, ELIZABETH
|
HARVARD MEDICAL SCHOOL
|
MA
|
$343,531
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
5K01AG042498-06
|
|
Preclinical Alzheimer's Disease Biomarkers: Effects of Midlife Vascular Factors
|
WHARTON, WHITNEY
|
EMORY UNIVERSITY
|
GA
|
$113,802
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NHLBI
|
5R01HL089067-09
|
|
Astrocytes regulation of vascular tone: role in hypertension
|
FILOSA, JESSICA
|
AUGUSTA UNIVERSITY
|
GA
|
$380,000
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIEHS
|
5R01ES026057-02
|
|
Mechanism of Gene Environment Interactions in Alzheimer's Disease
|
RICHARDSON, JASON
|
NORTHEAST OHIO MEDICAL UNIVERSITY
|
OH
|
$502,657
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
1R01AG053274-01A1
|
|
Actin and focal adhesion remodeling as therapeutic targets in cardiovascular disease
|
MORGAN, KATHLEEN
|
BOSTON UNIVERSITY (CHARLES RIVER CAMPUS)
|
MA
|
$519,328
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIDDK
|
5K23DK105327-02
|
|
The association of FGF-23 and Klotho with cognitive impairment and cerebrovascular disease in chronic kidney disease
|
DREW, DAVID
|
TUFTS MEDICAL CENTER
|
MA
|
$193,839
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NINDS
|
5R01NS029993-25
|
|
Risk Factors for Stroke and Cognitive Decline in a Tri-Ethnic Region
|
SACCO, RALPH
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
FL
|
$1,726,580
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
5R01AG049952-03
|
|
STALLED CAPILLARY FLOW: A NOVEL MECHANISM FOR HYPOPERFUSION IN ALZHEIMER DISEASE
|
SCHAFFER, CHRIS
|
CORNELL UNIVERSITY
|
NY
|
$327,794
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
5R01NS094201-02
|
|
The Role of Copper in Cerebral Amyloid Angiopathy
|
VAN NOSTRAND, WILLIAM
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
NY
|
$49,375
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NINDS
|
5R01NS094201-02
|
|
The Role of Copper in Cerebral Amyloid Angiopathy
|
VAN NOSTRAND, WILLIAM
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
NY
|
$347,708
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
1R01NS097722-01A1
|
|
Neurovascular astrocyte dysfunction in VCID
|
WILCOCK, DONNA
|
UNIVERSITY OF KENTUCKY
|
KY
|
$375,875
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NHLBI
|
5U01HL096814-07
|
|
ARIC Neurocognitive Study (ARIC-NCS) Renewal 4 of 5
|
WAGENKNECHT, LYNNE
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
NC
|
$326,537
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
5U01HL096814-07
|
|
ARIC Neurocognitive Study (ARIC-NCS) Renewal 4 of 5
|
WAGENKNECHT, LYNNE
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
NC
|
$150,000
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIDCD
|
5U01HL096814-07
|
|
ARIC Neurocognitive Study (ARIC-NCS) Renewal 4 of 5
|
WAGENKNECHT, LYNNE
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
NC
|
$75,000
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NINDS
|
5U01HL096814-07
|
|
ARIC Neurocognitive Study (ARIC-NCS) Renewal 4 of 5
|
WAGENKNECHT, LYNNE
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
NC
|
$300,000
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NHLBI
|
5U01HL096812-07
|
|
ARIC Neurocognitive Study (ARIC-NCS) 1 of 5
|
CORESH, JOSEF
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$783,353
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
5U01HL096812-07
|
|
ARIC Neurocognitive Study (ARIC-NCS) 1 of 5
|
CORESH, JOSEF
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$150,000
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIDCD
|
5U01HL096812-07
|
|
ARIC Neurocognitive Study (ARIC-NCS) 1 of 5
|
CORESH, JOSEF
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$200,000
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NINDS
|
5U01HL096812-07
|
|
ARIC Neurocognitive Study (ARIC-NCS) 1 of 5
|
CORESH, JOSEF
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$300,000
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NHLBI
|
5U01HL096899-07
|
|
ARIC Neurocognitive Study (ARIC-NCS) Renewal UNC 4 of 5
|
COUPER, DAVID
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$84,903
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
5U01HL096899-07
|
|
ARIC Neurocognitive Study (ARIC-NCS) Renewal UNC 4 of 5
|
COUPER, DAVID
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$150,000
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIDCD
|
5U01HL096899-07
|
|
ARIC Neurocognitive Study (ARIC-NCS) Renewal UNC 4 of 5
|
COUPER, DAVID
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$75,000
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NINDS
|
5U01HL096899-07
|
|
ARIC Neurocognitive Study (ARIC-NCS) Renewal UNC 4 of 5
|
COUPER, DAVID
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$300,000
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
1R01AG054073-01A1
|
|
Health Disparities in Alzheimer's Disease and Mild Cognitive Impairment among Mexican Americans
|
O'BRYANT, SID
|
UNIVERSITY OF NORTH TEXAS HLTH SCI CTR
|
TX
|
$1,994,423
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
1R21AG055995-01
|
|
Chronic Stressors, Brain Vasculature, and Cognitive Function in African-American Women
|
LEWIS, TENÉ
|
EMORY UNIVERSITY
|
GA
|
$312,000
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NHLBI
|
5U01HL096902-07
|
|
ARIC Neurocognitive Study (ARIC-NCS)
|
LUTSEY, PAMELA
|
UNIVERSITY OF MINNESOTA
|
MN
|
$417,081
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
5U01HL096902-07
|
|
ARIC Neurocognitive Study (ARIC-NCS)
|
LUTSEY, PAMELA
|
UNIVERSITY OF MINNESOTA
|
MN
|
$150,000
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIDCD
|
5U01HL096902-07
|
|
ARIC Neurocognitive Study (ARIC-NCS)
|
LUTSEY, PAMELA
|
UNIVERSITY OF MINNESOTA
|
MN
|
$75,000
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NINDS
|
5U01HL096902-07
|
|
ARIC Neurocognitive Study (ARIC-NCS)
|
LUTSEY, PAMELA
|
UNIVERSITY OF MINNESOTA
|
MN
|
$300,000
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NHLBI
|
5U01HL096917-07
|
|
ARIC Neurocognitive Study (ARIC-NCS) Renewal 2 of 5
|
MOSLEY, THOMAS
|
UNIVERSITY OF MISSISSIPPI MED CTR
|
MS
|
$387,620
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
5U01HL096917-07
|
|
ARIC Neurocognitive Study (ARIC-NCS) Renewal 2 of 5
|
MOSLEY, THOMAS
|
UNIVERSITY OF MISSISSIPPI MED CTR
|
MS
|
$150,000
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIDCD
|
5U01HL096917-07
|
|
ARIC Neurocognitive Study (ARIC-NCS) Renewal 2 of 5
|
MOSLEY, THOMAS
|
UNIVERSITY OF MISSISSIPPI MED CTR
|
MS
|
$75,000
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NINDS
|
5U01HL096917-07
|
|
ARIC Neurocognitive Study (ARIC-NCS) Renewal 2 of 5
|
MOSLEY, THOMAS
|
UNIVERSITY OF MISSISSIPPI MED CTR
|
MS
|
$300,000
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NHLBI
|
1R01HL133684-01A1
|
|
Women's Health Initiative Sleep Hypoxia Effects on Resilience (WHISPER)
|
BAKER, LAURA
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
NC
|
$2,183,569
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
2R37AG027924-12
|
|
ApoE pathway in cerebrovascular Aβ clearance in Alzheimer’s disease
|
BU, GUOJUN
|
MAYO CLINIC JACKSONVILLE
|
FL
|
$606,716
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
1R01AG053555-01A1
|
|
Neuroimaging biomarkers for cognitive decline in elderly with amyloid pathology
|
YASSA, MICHAEL
|
UNIVERSITY OF CALIFORNIA-IRVINE
|
CA
|
$756,327
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NINDS
|
1R01NS097876-01A1
|
|
Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial - Hemodynamics (CREST-H)
|
MARSHALL, RANDOLPH
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
NY
|
$714,544
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NHLBI
|
5R01HL092259-09
|
|
CEREBRAL AUTOREGULATION MONITORING TO REDUCE BRAIN INJURY FROM CARDIAC SURGERY
|
HOGUE, CHARLES
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
IL
|
$353,003
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
1R01NS097775-01A1
|
|
Deciphering the Cerebral Microinfarct and its Role in Vascular Cognitive Impairment
|
SHIH, ANDY
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
SC
|
$585,924
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
1R21AG052860-01A1
|
|
Perivascular Transport of Solutes from the Brain
|
CHIAROT, PAUL
|
STATE UNIVERSITY OF NY,BINGHAMTON
|
NY
|
$243,412
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
5P50AG008702-28
|
8838
|
Clinical Core
|
HONIG, LAWRENCE
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
NY
|
$793,888
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
5P50AG008702-28
|
8842
|
Satellite Diagnostic and Treatment Clinic Core
|
HONIG, LAWRENCE
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
NY
|
$67,440
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
5K23AG045966-04
|
|
Cognitive Complaints in Aging Adults
|
GIFFORD, KATHERINE
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
TN
|
$162,688
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
5K25AG051782-02
|
|
Hemodynamic Biomarkers of Healthy and Diseased Aging
|
ANDERSON, ARIANA
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$130,180
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
5K24AG052573-02
|
|
Neuroepidemiology of the vascular contribution to cognitive impairment and Alzheimer's disease
|
GOTTESMAN, REBECCA
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$160,504
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NINDS
|
5R01NS045847-11
|
|
White matter hypoxia in a novel model of MMP-mediated inflammation in SHR/SP
|
ROSENBERG, GARY
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
NM
|
$331,406
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NINDS
|
1F31NS090866-01A1
|
|
The effects of endothelial mineralocorticoid receptors in cerebral artery remodeling and endothelial injury
|
DIAZ-OTERO, JANICE
|
MICHIGAN STATE UNIVERSITY
|
MI
|
$43,576
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NINDS
|
5R01NS089515-04
|
|
The Role of Perlecan Domain V in Vascular Dementia
|
BIX, GREGORY
|
UNIVERSITY OF KENTUCKY
|
KY
|
$329,219
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NINDS
|
5R01NS094137-03
|
|
The role of Clusterin in cerebral amyloid angiopathy
|
FRYER, JOHN
|
MAYO CLINIC JACKSONVILLE
|
FL
|
$342,344
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
5R01NS092610-02
|
|
PATHOBIOLOGICAL STUDIES OF VESSEL BACE1 IN CEREBROVASCULAR AMYLOID ANGIOPATHY
|
SHEN, YONG
|
ROSKAMP INSTITUTE, INC.
|
FL
|
$50,000
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NINDS
|
5R01NS092610-02
|
|
PATHOBIOLOGICAL STUDIES OF VESSEL BACE1 IN CEREBROVASCULAR AMYLOID ANGIOPATHY
|
SHEN, YONG
|
ROSKAMP INSTITUTE, INC.
|
FL
|
$350,000
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
5R01AG052528-02
|
|
Development of a PET Tracer Selective for Cerebral Amyloid Angiopathy
|
IKONOMOVIC, MILOS
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$649,335
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
5R01AG054069-02
|
|
The Macrovascular and Microvascular Contributions to Alzheimer's Disease: MESA VASCAD
|
HUGHES, TIMOTHY
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
NC
|
$759,041
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
5K23AG046363-03
|
|
Cerebrovascular Reactivity in the Presence of Cerebral Amyloid and Cerebrovascular Disease: A novel multi-modal imaging measure of vascular reserve in cognitively normal elderly
|
MCDADE, ERIC
|
WASHINGTON UNIVERSITY
|
MO
|
$137,591
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
5R21AG052423-02
|
|
Reverse apoE4 effects by apoE2 expression in Alzheimer's disease
|
KANEKIYO, TAKAHISA
|
MAYO CLINIC JACKSONVILLE
|
FL
|
$234,750
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
5R01NS097495-02
|
|
Development, Validation, and Application of an Imaging based CVD Scale
|
VEMURI, PRASHANTHI
|
MAYO CLINIC ROCHESTER
|
MN
|
$538,598
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
5R21AG054092-02
|
|
What is the relationship between BOLD fMRI and functional MRS in aging and MCI?
|
STARK, CRAIG
|
UNIVERSITY OF CALIFORNIA-IRVINE
|
CA
|
$193,125
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
5P30AG049638-02
|
7046
|
Core B: Clinical Core
|
SINK, KAYCEE
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
NC
|
$479,618
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
5P30AG049638-02
|
7050
|
Core G: MESA Core
|
RAPP, STEPHEN
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
NC
|
$444,203
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
5R21AG050898-02
|
|
Cognitive Enhancement Through Transcranial Laser Therapy
|
HALEY, ANDREANA
|
UNIVERSITY OF TEXAS, AUSTIN
|
TX
|
$193,340
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
5R01AG051545-02
|
|
Hyperbaric oxygen therapy for cognition in diabetic elderly at high dementia risk
|
SCHNAIDER BEERI, MICHAL
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
NY
|
$611,657
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
5R01AG051635-02
|
|
Nonlinear Models of Cognition Preceding AD and non-AD in a Biracial Population Sample
|
RAJAN, KUMAR
|
RUSH UNIVERSITY MEDICAL CENTER
|
IL
|
$271,250
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
5R21AG052097-02
|
|
Determining if Reduced Insulin Response in the Brain is Linked to Cognitive Loss
|
JONGENS, THOMAS
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$197,637
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NINDS
|
5R01NS094681-03
|
|
Imaging neuronal and capillary dysfunction deep in the rodent brain in vivo using 1700 nm Optical Coherence Microscopy and tracer-based kinetics
|
SRINIVASAN, VIVEK
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
CA
|
$335,202
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
1R01AG054328-01A1
|
|
Role of Myeloid Cells in Cerebrovascular Permeability and Reactivity in Older HIV Infected Individuals
|
SCHIFITTO, GIOVANNI
|
UNIVERSITY OF ROCHESTER
|
NY
|
$715,820
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
1R44AG054256-01A1
|
|
Characterizing Alzheimer's Disease with INSPECDS: Integrated Neurocognitive and Sleep-Behavior Profiler for the Endophenotypic Classification of Dementia Subtypes
|
BERKA, CHRIS
|
ADVANCED BRAIN MONITORING, INC.
|
CA
|
$538,507
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
5R01AG052412-02
|
|
Eye Determinants of Cognition (EyeDOC) Study
|
ABRAHAM, ALISON
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$711,223
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
5R01AG040282-07
|
|
The ARIC-PET Amyloid Imaging Study
|
GOTTESMAN, REBECCA
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$723,709
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
5R01AG053938-02
|
|
Changes in arterial stiffness, cognition and dementia risk in a diverse cohort
|
HEISS, GERARDO
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$730,015
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
5P50AG005136-34
|
5232
|
Satellite Core Expansion (SCE): Cognitive Impairment, Alzheimer's Disease and Vascular Brain Injury in American Indians
|
BUCHWALD, DEDRA
|
UNIVERSITY OF WASHINGTON
|
WA
|
$633,563
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
5R21AG049332-02
|
|
Differences in Pain Between Alzheimer's Disease and Vascular Dementia in Older Females
|
MONROE, TODD
|
VANDERBILT UNIVERSITY
|
TN
|
$196,250
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
5P01AG052350-02
|
8219
|
Admin-Core-001
|
ZLOKOVIC, BERISLAV
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
CA
|
$156,950
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
5P01AG052350-02
|
8220
|
Core-001
|
ZLOKOVIC, BERISLAV
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
CA
|
$218,825
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
5P01AG052350-02
|
8221
|
Core-002
|
ZLOKOVIC, BERISLAV
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
CA
|
$214,059
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
5P01AG052350-02
|
8222
|
Project-001
|
ZLOKOVIC, BERISLAV
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
CA
|
$632,907
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
5P01AG052350-02
|
8223
|
Project-002
|
ZLOKOVIC, BERISLAV
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
CA
|
$722,151
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
5P01AG052350-02
|
8224
|
Project-003
|
ZLOKOVIC, BERISLAV
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
CA
|
$494,313
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
5U24NS100591-02
|
|
VCID Biomarker's Coordinating Center
|
GREENBERG, STEVEN
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$1,276,820
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
5R01NS100447-02
|
|
ApoE4 and mechanisms of diffuse white matter injury
|
IADECOLA, COSTANTINO
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
NY
|
$704,328
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
5UH2NS100614-02
|
|
Imaging Cerebral and Retinal Microvasculature in Cerebral Small Vessel Disease
|
WANG, DANNY
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
CA
|
$1,191,714
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
5UH2NS100598-02
|
|
MRI and CSF Biomarkers of White Matter Injury in VCID
|
ROSENBERG, GARY
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
NM
|
$1,064,133
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
5UH2NS100608-02
|
|
Novel imaging and endothelial biomarkers of small vessel cerebrovascular disease
|
KRAMER, JOEL
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
CA
|
$1,016,315
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NINDS
|
5R21NS099783-02
|
|
Identification and functional analysis of novel human-specific small vessel disease proteins
|
WANG, MICHAEL
|
UNIVERSITY OF MICHIGAN
|
MI
|
$157,500
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
5UH2NS100121-02
|
|
Exploring the Role of Aging in Cerebral Ischemic Small Vessel Disease Using Notch3 Mutant Mice
|
ARBOLEDA-VELASQUEZ, JOSEPH
|
SCHEPENS EYE RESEARCH INSTITUTE
|
MA
|
$138,926
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
5UH2NS100588-02
|
|
Development of MRI microvascular biomarkers in cognitive impairment and dementia
|
LU, HANZHANG
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$1,082,071
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
5UH2NS100605-02
|
|
Microglial, Inflammatory and Omics Markers of Cerebral Small Vessel Disease in the CHARGE Consortium
|
SESHADRI, SUDHA
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
MA
|
$1,001,222
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
5R01NS100459-02
|
|
The role of pericytes in white matter disease
|
ZLOKOVIC, BERISLAV
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
CA
|
$722,149
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
5R01NS100366-02
|
|
Para-Vascular Basis of Small Vessel Disease
|
NEDERGAARD, MAIKEN
|
UNIVERSITY OF ROCHESTER
|
NY
|
$769,002
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
5UH2NS100606-02
|
|
Small vessel disease biomarkers in a longitudinally-followed "stroke-belt" cohort
|
WILCOCK, DONNA
|
UNIVERSITY OF KENTUCKY
|
KY
|
$707,397
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
1R01AG056329-01
|
|
Bio-medical and socio-economic precursors of cognitive decline in SHARE
|
BOERSCH-SUPAN, AXEL
|
MAX PLANCK INST/SOCIAL LAW/SOCIAL POLICY
|
GERM
|
$432,000
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NHLBI
|
1R01HL137694-01
|
|
Cerebral parenchymal arteriole dysfunction and cognitive decline in a life-long high fat feeding model
|
DORRANCE, ANNE
|
MICHIGAN STATE UNIVERSITY
|
MI
|
$530,663
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
1R01NS102845-01
|
|
Innate Immunity Stimulation via CpG ODN in a Non-Human Primate Model of Sporadic Cerebral Amyloid Angiopathy
|
SCHOLTZOVA, HENRIETA
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
NY
|
$680,059
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
1R01AG056534-01
|
|
White matter and small vessel disease in older adults
|
JEFFERSON, ANGELA
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
TN
|
$648,931
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
1R03AG056448-01
|
|
In search of an ethno-culturally appropriate approach for the early identification of Cognitive Impairment in African Americans
|
GARRETT, STEPHANIE
|
EMORY UNIVERSITY
|
GA
|
$117,000
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
1R21AG056862-01
|
|
Role of blood-brain barrier interleukin-17 receptor A in Alzheimer disease
|
FUKUCHI, KEN-ICHIRO
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
IL
|
$199,875
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
1K25AG056594-01
|
|
Intracranial Vascular Compliance as an Early Imaging Marker of Alzheimer's Disease
|
YAN, LIRONG
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
CA
|
$150,676
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NCI
|
1R21CA218625-01
|
|
Memantine for Prevention of Cognitive Late Effects in Pediatric Patients Receiving Cranial Radiation Therapy for Low Grade Glioma
|
CONKLIN, HEATHER
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
TN
|
$156,165
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
5F30AG055283-02
|
|
Developing quantitative biomarkers for monitoring longitudinal changes in brain microvascular health
|
CERJANIC, ALEXANDER
|
UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN
|
IL
|
$49,044
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
1R01NS099455-01A1
|
|
Mechanisms of Chronic Remote Ischemic Conditioning Induced Cerebroprotection in a VCID Model
|
HESS, DAVID
|
AUGUSTA UNIVERSITY
|
GA
|
$380,000
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
1R01AG054476-01A1
|
|
Diet Patterns and Alzheimer Disease and Other Dementias
|
MORRIS, MARTHA
|
RUSH UNIVERSITY MEDICAL CENTER
|
IL
|
$379,466
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIDCD
|
1R01DC015466-01A1
|
|
Recovery of Affective Prosody after Stroke
|
HILLIS, ARGYE
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$672,386
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
1K01AG054693-01A1
|
|
Role and Mechanism of Hearing Impairment in Cognitive Decline and Dementia
|
DEAL, JENNIFER
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$129,361
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NINDS
|
1R21NS100006-01A1
|
|
Development of techniques to map cerebrovascular reactivity with resting-state MRI
|
LIU, PEIYING
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$204,375
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
5F30AG054115-02
|
|
Two Diseases or one? The early pathogenesis of vascular mediated cognitive decline and Alzheimer's Disease.
|
BERMAN, SARA
|
UNIVERSITY OF WISCONSIN-MADISON
|
WI
|
$40,698
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
1R21AG054876-01A1
|
|
Treatment of mild cognitive impairment with transcutaneous vagal nerve stimulation
|
WILLIAMSON, JOHN
|
UNIVERSITY OF FLORIDA
|
FL
|
$228,750
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
1K76AG057015-01
|
|
Cerebral Microbleeds in the Aging Population
|
GRAFF-RADFORD, JONATHAN
|
MAYO CLINIC ROCHESTER
|
MN
|
$243,000
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
1RF1AG057033-01
|
|
Air pollution, the social environment, and Alzheimer's disease: Risk and resilience in the Ginkgo Evaluation Memory Study
|
KAUFMAN, JOEL
|
UNIVERSITY OF WASHINGTON
|
WA
|
$2,288,624
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
1R01NS101718-01A1
|
|
Whole Genome RNA Sequencing (RNAseq) of Blood from Patients with Lacunar Stroke
|
SHARP, FRANK
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
CA
|
$130,225
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NINDS
|
1R01NS101718-01A1
|
|
Whole Genome RNA Sequencing (RNAseq) of Blood from Patients with Lacunar Stroke
|
SHARP, FRANK
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
CA
|
$497,942
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
2R01NS037853-20
|
|
Overexpression of the amyloid precursor protein and cerebrovascular regulation
|
IADECOLA, COSTANTINO
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
NY
|
$50,362
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NINDS
|
2R01NS037853-20
|
|
Overexpression of the amyloid precursor protein and cerebrovascular regulation
|
IADECOLA, COSTANTINO
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
NY
|
$352,538
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIMH
|
1R01MH114969-01
|
|
3/5 Neurocognitive and neuroimaging biomarkers: predicting progression towards dementia in patients with treatment resistant late-life depression
|
BUTTERS, MERYL
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$452,360
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIMH
|
1R01MH114970-01
|
|
1/5 Neurocognitive and neuroimaging biomarkers: predicting progression towards dementia in patients with treatment-resistant late-life depression
|
VOINESKOS, ARISTOTLE
|
CENTRE FOR ADDICTION AND MENTAL HEALTH
|
CANADA
|
$390,177
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIMH
|
1R01MH114980-01
|
|
2/5 Neurocognitive and neuroimaging biomarkers: predicting progression towards dementia in patients with treatment resistant late-life depression.
|
BROWN, PATRICK
|
NEW YORK STATE PSYCHIATRIC INSTITUTE
|
NY
|
$323,890
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIMH
|
1R01MH114981-01
|
|
4/5 Neurocognitive and neuroimaging biomarkers: predicting progression towards dementia in late-life depression
|
LAVRETSKY, HELEN
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$359,548
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
1RF1AG057531-01
|
|
COSMIC: An international consortium to identify risk and protective factors and biomarkers of cognitive ageing and dementia in diverse ethno-racial groups and geographical settings
|
SACHDEV, PERMINDER
|
UNIVERSITY OF NEW SOUTH WALES
|
AUSTRA
|
$2,573,572
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIMH
|
1R01MH114966-01
|
|
5/5 Neurocognitive and neuroimaging biomarkers: predicting progression toward dementia in patients with treatment resistant late-life depression
|
SHIMONY, JOSHUA
|
WASHINGTON UNIVERSITY
|
MO
|
$305,389
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
1R01AG057552-01
|
|
Exercise for Brain Health with Increased Genetic Risk for Alzheimer's Disease
|
SMITH, JEROME
|
UNIV OF MARYLAND, COLLEGE PARK
|
MD
|
$775,183
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
1R01AG057525-01
|
|
Neurovascular dysfunction in delirium superimposed on dementia
|
TERRANDO, NICCOLO
|
DUKE UNIVERSITY
|
NC
|
$564,455
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
1UF1AG057707-01
|
|
Neuropathologic substrates for motor and cognitive impairment in three existing cohort studies of Alzheimer's disease and related dementias
|
MONTINE, THOMAS
|
STANFORD UNIVERSITY
|
CA
|
$3,880,240
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
1RF1AG057928-01
|
|
Claudin Expression Profiles and Blood Brain Barrier in Aging
|
ANDJELKOVIC-ZOCHOWSKA, ANUSKA
|
UNIVERSITY OF MICHIGAN
|
MI
|
$2,343,371
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
1RF1AG057576-01
|
|
Glymphatic Clearance of Abeta is Impaired by Fibronectin in the Basement Membrane
|
URAYAMA, AKIHIKO
|
UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON
|
TX
|
$2,160,375
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
3R01AG034962-07S1
|
|
Cardiac function as a mechanism for maladaptive brain aging
|
JEFFERSON, ANGELA
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
TN
|
$665,005
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NINDS
|
1R01NS100980-01A1
|
|
Cardiovascular predictors of cerebrovascular health in older adults
|
JEFFERSON, ANGELA
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
TN
|
$521,391
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIMHD
|
1R03MD011306-01A1
|
|
Racial Differences in Arterial Stiffness and Cognitive Function.
|
HEFFERNAN, KEVIN
|
SYRACUSE UNIVERSITY
|
NY
|
$75,000
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
1RF1AG058273-01
|
|
Neuroinflammatory mechanisms of aging-related vascular cognitive impairment (VCI)
|
ALKAYED, NABIL
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
OR
|
$2,495,260
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
1R43AG058350-01
|
|
Development of a Novel Diagnostic Probe for Cerebral Amyloid Angiopathy
|
SARRAF, STELLA
|
AMYDIS DIAGNOSTICS, INC.
|
CA
|
$534,525
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NINDS
|
1F31NS105455-01
|
|
The role of T-lymphocytes and antibodies in B-lymphocyte mediated post-stroke cognitive decline
|
ZBESKO, JACOB
|
UNIVERSITY OF ARIZONA
|
AZ
|
$34,936
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
1F32AG058395-01
|
|
Cerebral Hemodynamics, Neurodegeneration, & Cognitive Aging
|
OSBORN, KATIE
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
TN
|
$56,694
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
1RF1AG058463-01
|
|
Dynamic Non-Neuronal Interactions between the Gut Microbiota and the Brain in Aging and in Cerebral Amyloid Angiopathy
|
MCCULLOUGH, LOUISE
|
UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON
|
TX
|
$3,731,831
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
3RF1AG051633-01S2
|
|
The role of the renin-angiotensin-endothelial pathway in AD
|
HAJJAR, IHAB
|
EMORY UNIVERSITY
|
GA
|
$298,038
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIMHD
|
2U54MD000507-15
|
7301
|
Longitudinal Study of MRI, Clinical, and Genetic Biomarkers of Cognitive Impairment and Alzheimer's Disease in Elderly American Indians
|
BUCHWALD, DEDRA
|
WASHINGTON STATE UNIVERSITY
|
WA
|
$336,434
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
3P50AG044170-05S1
|
5793
|
Effects of Menopausal Hormone Therapy on Imaging Markers of Cognitive Health
|
MILLER, VIRGINIA
|
MAYO CLINIC ROCHESTER
|
MN
|
$22,567
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
OD
|
3P50AG044170-05S1
|
5793
|
Effects of Menopausal Hormone Therapy on Imaging Markers of Cognitive Health
|
MILLER, VIRGINIA
|
MAYO CLINIC ROCHESTER
|
MN
|
$165,500
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
3P50AG044170-05S1
|
5794
|
Markers of Cerebrovascular Dysfunction in Women at Risk
|
MILLER, VIRGINIA
|
MAYO CLINIC ROCHESTER
|
MN
|
$20,181
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
OD
|
3P50AG044170-05S1
|
5794
|
Markers of Cerebrovascular Dysfunction in Women at Risk
|
MILLER, VIRGINIA
|
MAYO CLINIC ROCHESTER
|
MN
|
$148,004
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
3R01AG045154-04S1
|
|
Processing Speed Training to Preserve Driving and Functional Competencies in MCI
|
WADLEY BRADLEY, VIRGINIA
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$145,775
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
3R01AG049084-02S1
|
|
Rhythm and Timing Exercises for Cerebral Vascular Disease in American Indians - Diversity Supplement Resubmission
|
VERNEY, STEVEN
|
UNIVERSITY OF NEW MEXICO
|
NM
|
$113,229
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
3P30AG049638-02S1
|
|
Wake Forest Alzheimer's Disease Core Center
|
CRAFT, SUZANNE
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
NC
|
$155,000
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
7RF1AG054442-02
|
|
Brain atrophy, cognitive impairment and Alzheimer's in a low CVD-risk population
|
KAPLAN, HILLARD
|
CHAPMAN UNIVERSITY
|
CA
|
$3,487,316
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NCI
|
3U01AG029824-07S1
|
|
ASPirin in Reducing Events in the Elderly
|
MURRAY, ANNE
|
MINNEAPOLIS MEDICAL RESEARCH FDN, INC.
|
MN
|
$586,270
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
3U01AG029824-07S1
|
|
ASPirin in Reducing Events in the Elderly
|
MURRAY, ANNE
|
MINNEAPOLIS MEDICAL RESEARCH FDN, INC.
|
MN
|
$350,054
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
7R21NS096972-03
|
|
Cerebral Hemodynamics and Neurocognition in Severe Aortic Valve Disease
|
LAZAR, RONALD
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$185,625
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
3R01AG021055-15S1
|
|
Clinical, Imaging, and Pathological Studies in the Oldest Old: The 90+ Study
|
KAWAS, CLAUDIA
|
UNIVERSITY OF CALIFORNIA-IRVINE
|
CA
|
$126,000
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
3RF1AG054442-02S1
|
|
Brain atrophy, cognitive impairment and Alzheimer's in a low CVD-risk population
|
KAPLAN, HILLARD
|
CHAPMAN UNIVERSITY
|
CA
|
$135,924
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NIA
|
1R56AG057548-01
|
|
The biological underpinnings of Motoric Cognitive Risk syndrome: a multi-center study
|
VERGHESE, JOE
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
NY
|
$1,205,573
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NINDS
|
1ZIANS002924-22
|
|
Protective Mechanisms In Cerebral Ischemia
|
HALLENBECK, JOHN
|
NIH
|
|
$914,331
|
|
Vascular Cognitive Impairment/Dementia
|
2017
|
NINDS
|
1ZIANS003151-03
|
|
Using MRI to Understand Disease States that Occur at the Interface of the Brain and the Cerebral Circulation
|
LEIGH, RICHARD
|
NIH
|
|
$793,523
|
